YOKNEAM, Israel, March 24, 2026 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and ...

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that ...

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that ...

YOKNEAM, Israel, March 24, 2026 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and ...

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share ...

InMode Ltd. INMD shares are up during Friday’s premarket session after the company announced a new share repurchase program. InMode’s Board of Directors has authorized a new share repurchase program ...

On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.

InMode shares were 6% higher, at $13.48, after the company said its board of directors has authorized a new share repurchase program for up to 10% of its total shares outstanding. The medical ...

YOKNEAM, Israel - InMode Ltd. (NASDAQ:INMD) announced today that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the company’s total shares ...

On Monday, 16 March 2026, InMode Ltd (NASDAQ:INMD) participated in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The company outlined its strategic initiatives amidst ...